Studies have shown that CXCR7 promoted EMT and migration and/or invasion abilities in bladder cancer (Hao et al., 2012), lung cancer (Wu et al., 2016) and breast cancer (Li et al., 2015). This evidence concerns the gene ACKR3 and lung carcinoma.